Sherrin T, Blank T, Saravana R, Rayner M, Spiess J, Todorovic C
Specialized Neuroscience Research Project 2, John A. Burns School of Medicine, University of Hawaii, 651 Ilalo Street, Honolulu, HI 96813, USA.
Neuroscience. 2009 Aug 4;162(1):14-22. doi: 10.1016/j.neuroscience.2009.04.012. Epub 2009 Apr 9.
We have previously reported that repeated central administration of sub-anxiogenic doses of the corticotropin releasing factor 1 (CRF(1)) agonist Cortagine, termed "priming," elicits a phenotype of increased anxiety-like behaviors in the elevated plus maze (EPM) and open-field test, and enhanced retention of contextual conditioned fear in C57BL/6J mice. Observed behavioral changes were functionally coupled to CRF(1)-mediated elevated central cholecystokinin (CCK) tone in discrete brain regions. However, the changes in gene expression that mediated "priming"-induced behavioral and concurrent molecular changes in specific brain regions remained unknown. In the present study, a complementary DNA microarray analysis was used to investigate gene expression profiles in the hippocampus and prefrontal cortex (PFC) of C57BL/6J mice following the "priming" procedure. Here, we report that chronic stimulation of CRF(1), by i.c.v. administration of 10 ng Cortagine for five days, brought about alterations in the expression of a wide range of hippocampal (31 genes) and PFC (18 genes) genes, implicated in anxiety and aversive memory formation. These expression changes involved genes associated with signal transduction, neurotransmitter secretion, synaptic transmission, myelination, and others involved in the transport, biosynthesis, and binding of proteins. In particular, several genes of the protein kinase A (PKA) and protein kinase C (PKC) signaling cascades, known to be involved in synaptic plasticity, such as neurogranin, calmodulin 3, and the PKA regulatory subunit 1 b were found to be upregulated in the PFC and hippocampus of CRF(1) agonist "primed" mice. Moreover, we show pharmacologically that one of the newly implicated memory regulatory elements, diazepam-binding inhibitor (DBI) is functionally involved in hippocampus-dependent enhancement of contextual fear, a cardinal phenotypic feature of the "primed" mice. Finally, an interaction network mapping of the altered genes and their known interacting partners identified additional molecular candidates responsible for CRF(1)-mediated hypersensitive fear circuitry.
我们之前报道过,反复向中枢给予亚致焦虑剂量的促肾上腺皮质激素释放因子1(CRF(1))激动剂Cortagine,即“启动”,会在高架十字迷宫(EPM)和旷场试验中引发焦虑样行为增加的表型,并增强C57BL/6J小鼠对情境性条件恐惧的记忆保持。观察到的行为变化在功能上与离散脑区中CRF(1)介导的中枢胆囊收缩素(CCK)水平升高有关。然而,介导“启动”诱导的特定脑区行为和并发分子变化的基因表达变化仍不清楚。在本研究中,我们使用互补DNA微阵列分析来研究“启动”程序后C57BL/6J小鼠海马体和前额叶皮质(PFC)中的基因表达谱。在此,我们报告,通过脑室内注射10 ng Cortagine连续五天对CRF(1)进行慢性刺激,导致大量海马体(31个基因)和PFC(18个基因)基因的表达发生改变,这些基因与焦虑和厌恶记忆形成有关。这些表达变化涉及与信号转导、神经递质分泌、突触传递、髓鞘形成相关的基因,以及其他参与蛋白质运输、生物合成和结合的基因。特别是,已知参与突触可塑性的蛋白激酶A(PKA)和蛋白激酶C(PKC)信号级联的几个基因,如神经颗粒蛋白、钙调蛋白3和PKA调节亚基1 b,在CRF(1)激动剂“启动”小鼠的PFC和海马体中被发现上调。此外,我们通过药理学方法表明,新涉及的记忆调节元件之一,地西泮结合抑制剂(DBI)在功能上参与了海马体依赖性情境恐惧增强,这是“启动”小鼠的一个主要表型特征。最后,对改变的基因及其已知相互作用伙伴的相互作用网络映射确定了负责CRF(1)介导的超敏恐惧回路的其他分子候选物。